Akasi Pharma
European Union (EU)
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.
Founded by
Investors:
BioInnovation Institute Venture Lab
Description:
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions, particularly diabetic peripheral neuropathic pain (DPNP). This condition affects a significant number of diabetics, with a lifetime incidence of about 50%, and is notoriously difficult to treat effectively with existing option
Key Metrics:
Total Raised
526075
Team Size
1-10
Location
Copenhagen
Denmark
Last Funding
February 25, 2025